NasdaqGM - Delayed Quote • USD
Amarin Corporation plc (AMRN)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 7:59 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | -0.03 | -0.03 | -0.14 | -0.13 |
| Low Estimate | -0.05 | -0.05 | -0.2 | -0.24 |
| High Estimate | -0.01 | -0.02 | -0.06 | 0.06 |
| Year Ago EPS | -0.04 | -0.04 | -0.15 | -0.14 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 3 |
| Avg. Estimate | 57.04M | 54.56M | 221.74M | 230.35M |
| Low Estimate | 46.6M | 43.8M | 185.1M | 168.7M |
| High Estimate | 67.2M | 66.5M | 267.8M | 332.7M |
| Year Ago Sales | 81.23M | -- | 306.91M | 221.74M |
| Sales Growth (year/est) | -29.80% | -- | -27.80% | 3.90% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.03 | -0.03 | -0.04 | -0.03 |
| EPS Actual | -0.04 | -0.04 | -0.05 | -0.01 |
| Difference | -0.01 | -0.01 | -0.01 | 0.02 |
| Surprise % | -33.30% | -33.30% | -25.00% | 66.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.03 | -0.03 | -0.14 | -0.13 |
| 7 Days Ago | -0.03 | -0.03 | -0.14 | -0.13 |
| 30 Days Ago | -0.03 | -0.03 | -0.14 | -0.13 |
| 60 Days Ago | -0.03 | -0.04 | -0.15 | -0.08 |
| 90 Days Ago | -0.02 | -0.03 | -0.16 | -0.12 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | AMRN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 25.00% | -- | -- | 1.50% |
| Next Qtr. | 25.00% | -- | -- | 11.40% |
| Current Year | 6.70% | -- | -- | 5.20% |
| Next Year | 7.10% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 38.90% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 65.14% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | Jefferies: Buy to Hold | 10/25/2023 |
| Maintains | Goldman Sachs: Sell to Sell | 7/20/2023 |
| Maintains | Northland Capital Markets: Market Perform to Market Perform | 7/19/2023 |
| Upgrade | Jefferies: Hold to Buy | 1/6/2023 |
| Maintains | SVB Leerink: Market Perform | 10/19/2022 |
| Maintains | Goldman Sachs: Sell | 5/24/2022 |
Related Tickers
SCLX Scilex Holding Company
0.8500
-12.97%
GILD Gilead Sciences, Inc.
67.08
+0.07%
BIIB Biogen Inc.
201.99
+4.56%
AZN AstraZeneca PLC
71.20
+0.49%
NVS Novartis AG
98.35
+1.10%
OGN Organon & Co.
18.71
+1.03%
MRK Merck & Co., Inc.
127.00
+0.09%
GSK GSK plc
40.86
-0.92%
SNY Sanofi
46.61
-2.26%
PFE Pfizer Inc.
26.27
-0.19%